| Date Filed | Type | Description |
| 06/16/2023 |
4
| Mohindru Mani (Director) has filed a Form 4 on CytomX Therapeutics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $1.57, valued at
$39.3k
|
|
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 12/18/2020 |
4
| Mohindru Mani (Director) has filed a Form 4 on CytomX Therapeutics, Inc.|
Txns:
| Granted 40,000 options to buy
@ $7.45, valued at
$298k
|
|
| 12/18/2020 |
3
| Mohindru Mani (Director) has filed a Form 3 on CytomX Therapeutics, Inc. |
| 12/04/2019 |
4
| Mohindru Mani (CFO & Chief Strategy Officer) has filed a Form 4 on Cara Therapeutics, Inc.|
Txns:
| Granted 8,333 shares
@ $0
Sold 4,755 shares
@ $17.05, valued at
$81.1k
|
|
| 07/17/2019 |
4
| Mohindru Mani (CFO & Chief Strategy Officer) has filed a Form 4 on Cara Therapeutics, Inc.|
Txns:
| Sold 37,431 shares
@ $25, valued at
$935.8k
Exercised 37,431 options to buy
@ $14.06, valued at
$526.3k
|
|
| 05/30/2019 |
4
| Mohindru Mani (CFO & Chief Strategy Officer) has filed a Form 4 on Cara Therapeutics, Inc.|
Txns:
| Granted 8,333 shares
@ $0
Sold 2,496 shares
@ $21.39, valued at
$53.4k
|
|
| 03/15/2019 |
4
| Mohindru Mani (CFO & Chief Strategy Officer) has filed a Form 4 on Cara Therapeutics, Inc.|
Txns:
| Sold 16,041 shares
@ $19.12, valued at
$306.7k
Exercised 16,041 options to buy
@ $14.06, valued at
$225.5k
|
|
| 03/08/2019 |
4
| Mohindru Mani (CFO & Chief Strategy Officer) has filed a Form 4 on Cara Therapeutics, Inc.|
Txns:
| Granted 75,000 options to buy
@ $16.1, valued at
$1.2M
|
|
| 01/02/2019 |
4
| Mohindru Mani (CFO & Chief Strategy Officer) has filed a Form 4 on Cara Therapeutics, Inc.|
Txns:
| Sold 4,500 shares
@ $12.55, valued at
$56.5k
|
|
| 12/31/2018 |
4
| Mohindru Mani (CFO & Chief Strategy Officer) has filed a Form 4 on Cara Therapeutics, Inc.|
Txns:
| Granted 12,526 shares
@ $0 |
|
| 11/16/2018 |
4
| Mohindru Mani (CFO & Chief Strategy Officer) has filed a Form 4 on Cara Therapeutics, Inc.|
Txns:
| Sold 16,042 shares
@ $18.5, valued at
$296.8k
Exercised 16,042 options to buy
@ $14.06, valued at
$225.6k
|
|
| 10/19/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/24/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/24/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/16/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/30/2016 |
4
| Mohindru Mani (Chief Strategy Officer) has filed a Form 4 on CURIS INC|
Txns:
| Granted 200,000 options to buy
@ $1.51, valued at
$302k
|
|